MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Expert Review of Pharmacoeconomics & Outcomes Research
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

174 results · 1 filter active ·
Results by year
20012025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
174 works in the cohort · of 4,299,418page 1 of 4

Labels cover 1 of 174 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 174 of 174 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Health utility estimation
George W. Torrance, William Furlong, David Feeny
2002· article· en· Expert Review of Pharmacoeconomics & Outcomes Research· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
110
citations
aboutno affunlabeled
The economic burden of psoriasis: a systematic literature review
Steven R. Feldman, Chakkarin Burudpakdee, Smeet Gala, Merena Nanavaty, Usha G. Mallya
2014· review· en· Expert Review of Pharmacoeconomics & Outcomes Research· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
81
citations
affunlabeled
One-year treatment costs of trauma care in the USA
Sharada Weir, David S. Salkever, Frederick P. Rivara, Gregory J. Jurkovich, Avery B. Nathens, Ellen J. MacKenzie
2010· article· en· Expert Review of Pharmacoeconomics & Outcomes Research· Medicine
machine prediction:candidate · noneconsensus · none
77
citations
affunlabeled
Risk equalization in The Netherlands: an empirical evaluation
Richard C. van Kleef, René CJA van Vliet, Wynand PMM van de Ven
2013· article· en· Expert Review of Pharmacoeconomics & Outcomes Research· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
51
citations
afffundunlabeled
Radiotherapy-induced nausea and vomiting
Kristopher Dennis, Ernesto Maranzano, Carlo DeAngelis, Lori Holden, C. Shun Wong, Edward Chow
2011· review· en· Expert Review of Pharmacoeconomics & Outcomes Research· Medicine
machine prediction:candidate · noneconsensus · none
28
citations
affunlabeled
Economic burden of cardiovascular diseases in China
Li Yang, Ming Wu, Bin Cui, Judy Xu
2008· article· en· Expert Review of Pharmacoeconomics & Outcomes Research· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
26
citations

How this was built: Screen · Findings · About